Agere Pharmaceuticals Overview
- Founded
-
2008

- Status
-
Acquired/Merged
- Employees
-
53

- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Agere Pharmaceuticals General Information
Description
Operator of a contract development and manufacturing organization (CDMO) in the pharmaceutical sector. The company specializes in improving the oral bioavailability of BCS II - IV compounds through fundamental science, solubilization expertise, and proprietary solubilization technologies.
Contact Information
Website
www.agerepharma.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Delivery
Acquirer
Primary Office
- 62925 NorthEast 18th Street
- Bend, OR 97701
- United States
Agere Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Agere Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Operator of a contract development and manufacturing organization (CDMO) in the pharmaceutical sector. The company speci
Biotechnology
Bend, OR
53
As of 2015
000
0000-00-00
000000&0
Agere Pharmaceuticals Competitors (1)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
000000000 00000000 | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 00000000 | 00000 |
Agere Pharmaceuticals Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Marshall Crew Ph.D | President & Chief Executive Officer |